Clinical Trials Logo

Clinical Trial Summary

This study evaluates the impact of intranasal oxytocin vs placebo in patients with obesity and binge eating disorder with obesity. We hypothesize that 8 weeks of intranasal oxytocin vs placebo will improve clinical outcomes [weight loss, reduction in bingeing frequency], and have a satisfactory safety and tolerability profile. We will also explore the predictive value of changes in homeostatic appetite, reward sensitivity, and impulse control, the identified underlying mediators, as assessed 4 weeks into the intervention, for treatment success after 8 weeks of the intervention


Clinical Trial Description

Study staff will screen patients for eligibility as per eligibility criteria. At least 60 eligible patients will be randomized 1:1 (active oxytocin: placebo) by an unblinded pharmacist. All other study staff and test subjects will be blinded. Study subject medical histories, physical exams, anthropometric measurements, labs, EKG's, and eating habits will be monitored over 8 weeks. Subjects will be evaluated at the following intervals: Baseline, week 2, week 4, and week 8. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05664516
Study type Interventional
Source Massachusetts General Hospital
Contact Sarah Smith, NP
Phone 617-726-9394
Email SSMITH133@MGH.HARVARD.EDU
Status Recruiting
Phase Phase 2
Start date March 7, 2023
Completion date April 2024

See also
  Status Clinical Trial Phase
Completed NCT04572087 - Ameliorating Cognitive Control in Binge Eating Disorder N/A
Completed NCT03063606 - Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment Phase 2/Phase 3
Completed NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Enrolling by invitation NCT04174703 - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing N/A
Terminated NCT03279731 - Binge Eating Liraglutide Intervention Phase 3
Terminated NCT04278755 - Binge Eating & Birth Control Phase 2
Completed NCT02419326 - Uniting Couples In the Treatment of Eating Disorders (UNITE) N/A
Completed NCT00210808 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity Phase 2/Phase 3
Recruiting NCT05937243 - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating N/A
Completed NCT04115852 - Interoceptive Nutritional Processing in Healthy Participants and Patients With Binge-Eating-Disorder
Completed NCT03113669 - Project BITE: Binge Intervention Target Effectiveness N/A
Completed NCT04265131 - Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome? N/A
Recruiting NCT06431854 - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program N/A
Completed NCT06230107 - The Effects of Nutritional Intervention in Participants With Eating Disorders. N/A
Completed NCT03712748 - Online Imaginal Exposure N/A
Recruiting NCT04076553 - Augmenting Cognitive Behavioral Therapy With Inhibitory Control Training N/A
Not yet recruiting NCT04101032 - eBEfree - an ICT Adaptation of BEfree N/A
Terminated NCT05911334 - Feasibility of the ROADE Program N/A
Completed NCT03317379 - Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy N/A
Completed NCT02783872 - Emotion Regulation and Binge Eating in Youth With Obesity